Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 3:33 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 0 0% | -521,691 (Position Closed) | View |
| 2023-02-13 3:24 pm Sale | 13G | APOLLO ENDOSURGERY INC APEN | LYTTON LAURENCE W | 3,403,180 6.7% | -286,740 (-7.77%) | View |
| 2023-02-13 3:14 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 482,430 4.99% | -3,695,362 (-88.45%) | View |
| 2023-02-13 2:55 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | LYTTON LAURENCE W | 2,667,333 7.1% | 803,218 (+43.09%) | View |
| 2023-02-10 7:02 pm Purchase | 13G | EMCORE CORP EMKR | LYTTON LAURENCE W | 2,923,271 7.8% | 879,370 (+43.02%) | View |
| 2023-01-19 6:34 pm Purchase | 13G | BIOLASE INC PAR $0.001 BIOL | LYTTON LAURENCE W | 2,461,094 9.99% | 2,461,094 (New Position) | View |
| 2022-11-23 2:40 pm Purchase | 13G | EXAGEN INC XGN | LYTTON LAURENCE W | 833,305 5.1% | 833,305 (New Position) | View |
| 2022-11-23 1:01 pm Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | LYTTON LAURENCE W | 3,137,641 8.8% | 3,137,641 (New Position) | View |
| 2022-05-20 6:45 pm Purchase | 13G | EMCORE CORP EMKR | LYTTON LAURENCE W | 2,043,901 5.4% | 1,391,115 (+213.10%) | View |
| 2022-05-18 4:47 pm Purchase | 13G | PARATEK PHARMACEUTICAL, INC CO PRTK | LYTTON LAURENCE W | 3,210,552 5.9% | 3,210,552 (New Position) | View |
| 2022-03-30 12:48 pm Purchase | 13G | SCIENTIFIC INDUSTRIES INC SCND | LYTTON LAURENCE W | 408,229 5.7% | 408,229 (New Position) | View |
| 2022-03-04 5:23 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | LYTTON LAURENCE W | 1,864,115 5.9% | 1,747,115 (+1493.26%) | View |
| 2022-02-15 4:57 pm Purchase | 13G | APOLLO ENDOSURGERY INC APEN | LYTTON LAURENCE W | 3,689,920 9.3% | 1,041,770 (+39.34%) | View |
| 2022-02-15 2:25 pm Sale | 13G | DIAMEDICA THERAPEUTI DMAC | LYTTON LAURENCE W | 1,071,970 4.1% | -308,296 (-22.34%) | View |
| 2022-02-15 2:18 pm Sale | 13G | Vertex Energy, Inc VTNR | LYTTON LAURENCE W | 3,649,067 5.7% | -444,494 (-10.86%) | View |
| 2022-02-15 2:16 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 521,691 6.8% | 37,279 (+7.70%) | View |
| 2022-02-15 1:50 pm Sale | 13G | RA MED SYS INC RMED | LYTTON LAURENCE W | 220,000 0.8% | -20,952 (-8.70%) | View |
| 2022-02-15 1:49 pm Sale | 13G | EMCORE CORP EMKR | LYTTON LAURENCE W | 652,786 1.8% | -1,065,517 (-62.01%) | View |
| 2022-02-15 1:48 pm Purchase | 13G | VIRACTA THERAPEUTICS INC VIRX | LYTTON LAURENCE W | 255,876 0.7% | 255,876 (New Position) | View |
| 2022-02-15 1:09 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | LYTTON LAURENCE W | 1,708,328 2.5% | -1,632,072 (-48.86%) | View |